Prime Medicine, Inc. short interest in 2023
In 2023, Prime Medicine, Inc.'s disclosed short interest ran from 2.28% of shares outstanding on 13 Jan 2023 to 7.55% on 29 Dec 2023, a change of +5.27 percentage points. The year's high was 7.82% on 31 Oct 2023 and its low 2.22% on 15 Feb 2023, averaging 4.99% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 26.98 days on 31 Aug 2023. Full history: Prime Medicine, Inc..
Cite this page
By year: 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 2.28% (13 Jan 2023)
- End of year
- 7.55% (29 Dec 2023)
- Change
- +5.27 pp
- High
- 7.82% (31 Oct 2023)
- Low
- 2.22% (15 Feb 2023)
- Average
- 4.99%
- Highest days to cover
- 26.98 (31 Aug 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 2.28% | 11.40 | |
| 31 Jan 2023 | 2.26% | 24.12 | |
| 15 Feb 2023 | 2.22% | 12.64 | |
| 28 Feb 2023 | 2.36% | 14.82 | |
| 15 Mar 2023 | 2.67% | 14.88 | 10-K filed, results (8-K) |
| 31 Mar 2023 | 3.06% | 14.38 | |
| 14 Apr 2023 | 3.68% | 14.91 | |
| 28 Apr 2023 | 4.10% | 16.98 | |
| 15 May 2023 | 4.16% | 13.87 | 10-Q filed, results (8-K) |
| 31 May 2023 | 3.84% | 13.76 | |
| 15 Jun 2023 | 3.70% | 8.03 | |
| 30 Jun 2023 | 5.59% | 6.09 | |
| 14 Jul 2023 | 5.59% | 22.56 | |
| 31 Jul 2023 | 4.93% | 18.82 | |
| 15 Aug 2023 | 5.21% | 17.51 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 5.23% | 26.98 | |
| 15 Sep 2023 | 5.65% | 7.52 | |
| 29 Sep 2023 | 7.71% | 25.56 | |
| 13 Oct 2023 | 7.77% | 16.19 | |
| 31 Oct 2023 | 7.82% | 13.53 | |
| 15 Nov 2023 | 7.54% | 12.58 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 7.25% | 13.59 | |
| 15 Dec 2023 | 7.55% | 10.23 | |
| 29 Dec 2023 | 7.55% | 20.07 |
See also: Prime Medicine, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.